ProVise Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,486
| Closed | -$1.31M | – | 334 |
|
|
2023
Q4 | $1.31M | Buy |
1,486
+47
| +3% | +$41.3K | 0.11% | 156 |
|
|
2023
Q3 | $1.18M | Buy |
+1,439
| New | +$1.18M | 0.11% | 155 |
|
|
2020
Q3 | – | Sell |
-848
| Closed | -$529K | – | 303 |
|
|
2020
Q2 | $529K | Buy |
+848
| New | +$529K | 0.08% | 180 |
|
|
2020
Q1 | – | Sell |
-610
| Closed | -$229K | – | 295 |
|
|
2019
Q4 | $229K | Buy |
+610
| New | +$229K | 0.03% | 276 |
|